Literature DB >> 14972021

Effects of coffee consumption on oxidative susceptibility of low-density lipoproteins and serum lipid levels in humans.

G S Yukawa1, M Mune, H Otani, Y Tone, X-M Liang, H Iwahashi, W Sakamoto.   

Abstract

Since little is known about how coffee intake affects low-density lipoprotein (LDL) oxidative susceptibility and serum lipid levels, we conducted an in vivo study in 11 healthy male students of Wakayama Medical University aged between 20 and 31 years fed an average Japanese diet. On days 1-7 of the study, the subjects drank mineral water. On day 7, the subjects began drinking coffee, 24 g total per day, for one week. This was followed by a one week "washout period" during which mineral water was consumed. Fasting peripheral venous blood samples were taken at the end of each one-week period. LDL oxidation lag time was approximately 8% greater (p < 0.01) after the coffee drinking period than the other periods. Serum levels of total cholesterol and LDL-cholesterol (LDL-C) and malondialdehyde (MDA) as thiobarbituric acid reactive substances (TBARS) were significantly decreased after the coffee drinking period. Finally, regular coffee ingestion may favorably affect cardiovascular risk status by modestly reducing LDL oxidation susceptibility and decreasing LDL-cholesterol and MDA levels.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14972021     DOI: 10.1023/b:biry.0000016354.05438.0f

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  23 in total

Review 1.  Current evidence for the use of coffee and caffeine to prevent age-related cognitive decline and Alzheimer's disease.

Authors:  A J Carman; P A Dacks; R F Lane; D W Shineman; H M Fillit
Journal:  J Nutr Health Aging       Date:  2014-04       Impact factor: 4.075

2.  Association between coffee consumption and an oxidative stress marker in women.

Authors:  Jui-Tung Chen; Kazuhiko Kotani
Journal:  Wien Klin Wochenschr       Date:  2015-03-19       Impact factor: 1.704

3.  Coffee consumption and calcified atherosclerotic plaques in the coronary arteries: The NHLBI Family Heart Study.

Authors:  Yash R Patel; Taraka V Gadiraju; R Curtis Ellison; Steven C Hunt; John Jeffrey Carr; Gerardo Heiss; Donna K Arnett; James S Pankow; J Michael Gaziano; Luc Djoussé
Journal:  Clin Nutr ESPEN       Date:  2017-01-01

4.  Protective effects of chlorogenic acid on acute hepatotoxicity induced by lipopolysaccharide in mice.

Authors:  Yuexin Xu; Jingwen Chen; Xiao Yu; Weiwei Tao; Fengrong Jiang; Zhimin Yin; Chang Liu
Journal:  Inflamm Res       Date:  2010-04-20       Impact factor: 4.575

Review 5.  The potential effects of chlorogenic acid, the main phenolic components in coffee, on health: a comprehensive review of the literature.

Authors:  Narges Tajik; Mahboubeh Tajik; Isabelle Mack; Paul Enck
Journal:  Eur J Nutr       Date:  2017-04-08       Impact factor: 5.614

6.  Coffee consumption and risk of cardiovascular events and all-cause mortality among women with type 2 diabetes.

Authors:  W L Zhang; E Lopez-Garcia; T Y Li; F B Hu; R M van Dam
Journal:  Diabetologia       Date:  2009-03-06       Impact factor: 10.122

7.  The effects of caffeine on L-arginine metabolism in the brain of rats.

Authors:  Ebru Ofluoglu; Hatice Pasaoglu; Aydin Pasaoglu
Journal:  Neurochem Res       Date:  2008-07-10       Impact factor: 3.996

8.  Effect of caffeine on the risk of coronary heart disease- A re-evaluation.

Authors:  J O Adebayo; A O Akinyinka; G A Odewole; J I Okwusidi
Journal:  Indian J Clin Biochem       Date:  2007-03

9.  The relationship of coffee consumption with mortality.

Authors:  Esther Lopez-Garcia; Rob M van Dam; Tricia Y Li; Fernando Rodriguez-Artalejo; Frank B Hu
Journal:  Ann Intern Med       Date:  2008-06-17       Impact factor: 25.391

10.  Coffee and tea consumption are inversely associated with mortality in a multiethnic urban population.

Authors:  Hannah Gardener; Tatjana Rundek; Clinton B Wright; Mitchell S V Elkind; Ralph L Sacco
Journal:  J Nutr       Date:  2013-06-19       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.